Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 2001 Jul 1;357(Pt 1):255–261. doi: 10.1042/0264-6021:3570255

Glucose regulates protein catabolism in ras-transformed fibroblasts through a lysosomal-dependent proteolytic pathway.

C Tournu 1, A Obled 1, M P Roux 1, M Ferrara 1, S Omura 1, D M Béchet 1
PMCID: PMC1221949  PMID: 11415457

Abstract

Transformed cells are exposed to heterogeneous microenvironments, including low D-glucose (Glc) concentrations inside tumours. The regulation of protein turnover is commonly impaired in many types of transformed cells, but the role of Glc in this regulation is unknown. In the present study we demonstrate that Glc controls protein turnover in ras-transformed fibroblasts (KBALB). The regulation by Glc of protein breakdown was correlated with modifications in the levels of lysosomal cathepsins B, L and D, while autophagic sequestration and non-lysosomal proteolytic systems (m- and mu-calpains and the zeta-subunit of the proteasome) remained unaffected. Lactacystin, a selective inhibitor of the proteasome, depressed proteolysis, but did not prevent its regulation by Glc. The sole inhibition of the cysteine endopeptidases (cathepsins B and L, and calpains) by E-64d [(2S,3S)-trans-epoxysuccinyl-L-leucylamido-3-methylbutane ethyl ester] was also not sufficient to alter the effect of Glc on proteolysis. The Glc-dependent increase in proteolysis was, however, prevented after optimal inhibition of lysosomal cysteine and aspartic endopeptidases by methylamine. We conclude that, in transformed cells, Glc plays a critical role in the regulation of protein turnover and that the lysosomal proteolytic capacity is mainly responsible for the control of intracellular proteolysis by Glc.

Full Text

The Full Text of this article is available as a PDF (169.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baggetto L. G. Deviant energetic metabolism of glycolytic cancer cells. Biochimie. 1992 Nov;74(11):959–974. doi: 10.1016/0300-9084(92)90016-8. [DOI] [PubMed] [Google Scholar]
  2. Ballard F. J., Knowles S. E., Wong S. S., Bodner J. B., Wood C. M., Gunn J. M. Inhibition of protein breakdown in cultured cells is a consistent response to growth factors. FEBS Lett. 1980 Jun 2;114(2):209–212. doi: 10.1016/0014-5793(80)81116-1. [DOI] [PubMed] [Google Scholar]
  3. Barrett A. J. Cellular proteolysis. An overview. Ann N Y Acad Sci. 1992 Dec 31;674:1–15. doi: 10.1111/j.1749-6632.1992.tb27472.x. [DOI] [PubMed] [Google Scholar]
  4. Blommaart E. F., Luiken J. J., Meijer A. J. Autophagic proteolysis: control and specificity. Histochem J. 1997 May;29(5):365–385. doi: 10.1023/a:1026486801018. [DOI] [PubMed] [Google Scholar]
  5. Board M., Humm S., Newsholme E. A. Maximum activities of key enzymes of glycolysis, glutaminolysis, pentose phosphate pathway and tricarboxylic acid cycle in normal, neoplastic and suppressed cells. Biochem J. 1990 Jan 15;265(2):503–509. doi: 10.1042/bj2650503. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Béchet D. M., Ferrara M. J., Mordier S. B., Roux M. P., Deval C. D., Obled A. Expression of lysosomal cathepsin B during calf myoblast-myotube differentiation. Characterization of a cDNA encoding bovine cathepsin B. J Biol Chem. 1991 Jul 25;266(21):14104–14112. [PubMed] [Google Scholar]
  7. Campbell P., Glover G. I., Gunn J. M. Inhibition of intracellular protein degradation by pepstatinyl, poly(L-lysine), and pepstatinyl-poly(L-lysine). Arch Biochem Biophys. 1980 Sep;203(2):676–680. doi: 10.1016/0003-9861(80)90225-8. [DOI] [PubMed] [Google Scholar]
  8. Casciari J. J., Sotirchos S. V., Sutherland R. M. Glucose diffusivity in multicellular tumor spheroids. Cancer Res. 1988 Jul 15;48(14):3905–3909. [PubMed] [Google Scholar]
  9. Casciari J. J., Sotirchos S. V., Sutherland R. M. Variations in tumor cell growth rates and metabolism with oxygen concentration, glucose concentration, and extracellular pH. J Cell Physiol. 1992 May;151(2):386–394. doi: 10.1002/jcp.1041510220. [DOI] [PubMed] [Google Scholar]
  10. Clark W. A., Jr, Zak R. Assessment of fractional rates of protein synthesis in cardiac muscle cultures after equilibrium labeling. J Biol Chem. 1981 May 25;256(10):4863–4870. [PubMed] [Google Scholar]
  11. Cockle S. M., Dean R. T. Distinct proteolytic mechanisms in serum-sufficient and serum-restricted fibroblasts. Transformed 3T3 cells fail to regulate proteolysis in relation to culture density only during serum-sufficiency. Biochem J. 1984 Jul 1;221(1):53–60. doi: 10.1042/bj2210053. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Cuervo A. M., Dice J. F. A receptor for the selective uptake and degradation of proteins by lysosomes. Science. 1996 Jul 26;273(5274):501–503. doi: 10.1126/science.273.5274.501. [DOI] [PubMed] [Google Scholar]
  13. Dick L. R., Cruikshank A. A., Destree A. T., Grenier L., McCormack T. A., Melandri F. D., Nunes S. L., Palombella V. J., Parent L. A., Plamondon L. Mechanistic studies on the inactivation of the proteasome by lactacystin in cultured cells. J Biol Chem. 1997 Jan 3;272(1):182–188. doi: 10.1074/jbc.272.1.182. [DOI] [PubMed] [Google Scholar]
  14. Garlick P. J., McNurlan M. A. Protein metabolism in the cancer patient. Biochimie. 1994;76(8):713–717. doi: 10.1016/0300-9084(94)90075-2. [DOI] [PubMed] [Google Scholar]
  15. Gottesman M. M., Cabral F. Purification and characterization of a transformation-dependent protein secreted by cultured murine fibroblasts. Biochemistry. 1981 Mar 17;20(6):1659–1665. doi: 10.1021/bi00509a039. [DOI] [PubMed] [Google Scholar]
  16. Gunn J. M., James G. Protein turnover in 3T3 cells transformed with the oncogene c-H-ras1. Biochem J. 1992 Apr 15;283(Pt 2):427–433. doi: 10.1042/bj2830427. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Hahn W. C., Counter C. M., Lundberg A. S., Beijersbergen R. L., Brooks M. W., Weinberg R. A. Creation of human tumour cells with defined genetic elements. Nature. 1999 Jul 29;400(6743):464–468. doi: 10.1038/22780. [DOI] [PubMed] [Google Scholar]
  18. Hershko A., Ciechanover A. The ubiquitin system. Annu Rev Biochem. 1998;67:425–479. doi: 10.1146/annurev.biochem.67.1.425. [DOI] [PubMed] [Google Scholar]
  19. Honn K. V., Timár J., Rozhin J., Bazaz R., Sameni M., Ziegler G., Sloane B. F. A lipoxygenase metabolite, 12-(S)-HETE, stimulates protein kinase C-mediated release of cathepsin B from malignant cells. Exp Cell Res. 1994 Sep;214(1):120–130. doi: 10.1006/excr.1994.1240. [DOI] [PubMed] [Google Scholar]
  20. Houri J. J., Ogier-Denis E., De Stefanis D., Bauvy C., Baccino F. M., Isidoro C., Codogno P. Differentiation-dependent autophagy controls the fate of newly synthesized N-linked glycoproteins in the colon adenocarcinoma HT-29 cell line. Biochem J. 1995 Jul 15;309(Pt 2):521–527. doi: 10.1042/bj3090521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Isidoro C., Baccino F. M., Hasilik A. Mis-sorting of procathepsin D in metastogenic tumor cells is not due to impaired synthesis of the phosphomannosyl signal. Int J Cancer. 1997 Mar 4;70(5):561–566. doi: 10.1002/(sici)1097-0215(19970304)70:5<561::aid-ijc12>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
  22. Katunuma N., Kominami E. Structure, properties, mechanisms, and assays of cysteine protease inhibitors: cystatins and E-64 derivatives. Methods Enzymol. 1995;251:382–397. doi: 10.1016/0076-6879(95)51142-3. [DOI] [PubMed] [Google Scholar]
  23. Kinbara K., Ishiura S., Tomioka S., Sorimachi H., Jeong S. Y., Amano S., Kawasaki H., Kolmerer B., Kimura S., Labeit S. Purification of native p94, a muscle-specific calpain, and characterization of its autolysis. Biochem J. 1998 Nov 1;335(Pt 3):589–596. doi: 10.1042/bj3350589. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Kristensen P., Johnsen A. H., Uerkvitz W., Tanaka K., Hendil K. B. Human proteasome subunits from 2-dimensional gels identified by partial sequencing. Biochem Biophys Res Commun. 1994 Dec 30;205(3):1785–1789. doi: 10.1006/bbrc.1994.2876. [DOI] [PubMed] [Google Scholar]
  25. Kumatori A., Tanaka K., Inamura N., Sone S., Ogura T., Matsumoto T., Tachikawa T., Shin S., Ichihara A. Abnormally high expression of proteasomes in human leukemic cells. Proc Natl Acad Sci U S A. 1990 Sep;87(18):7071–7075. doi: 10.1073/pnas.87.18.7071. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Lazarus D. D., Destree A. T., Mazzola L. M., McCormack T. A., Dick L. R., Xu B., Huang J. Q., Pierce J. W., Read M. A., Coggins M. B. A new model of cancer cachexia: contribution of the ubiquitin-proteasome pathway. Am J Physiol. 1999 Aug;277(2 Pt 1):E332–E341. doi: 10.1152/ajpendo.1999.277.2.E332. [DOI] [PubMed] [Google Scholar]
  27. Lazo P. A. Amino acids and glucose utilization by different metabolic pathways in ascites-tumour cells. Eur J Biochem. 1981 Jun;117(1):19–25. doi: 10.1111/j.1432-1033.1981.tb06297.x. [DOI] [PubMed] [Google Scholar]
  28. Liang X. H., Jackson S., Seaman M., Brown K., Kempkes B., Hibshoosh H., Levine B. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature. 1999 Dec 9;402(6762):672–676. doi: 10.1038/45257. [DOI] [PubMed] [Google Scholar]
  29. Lockwood T. D., Minassian I. A. Protein turnover and proliferation. Failure of SV-3T3 cells to increase lysosomal proteinases, increase protein degradation and cease net protein accumulation. Biochem J. 1982 Aug 15;206(2):251–258. doi: 10.1042/bj2060251. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Mazurek S., Michel A., Eigenbrodt E. Effect of extracellular AMP on cell proliferation and metabolism of breast cancer cell lines with high and low glycolytic rates. J Biol Chem. 1997 Feb 21;272(8):4941–4952. doi: 10.1074/jbc.272.8.4941. [DOI] [PubMed] [Google Scholar]
  31. McNurlan M. A., Heys S. D., Park K. G., Broom J., Brown D. S., Eremin O., Garlick P. J. Tumour and host tissue responses to branched-chain amino acid supplementation of patients with cancer. Clin Sci (Lond) 1994 Mar;86(3):339–345. doi: 10.1042/cs0860339. [DOI] [PubMed] [Google Scholar]
  32. Mordier S., Deval C., Béchet D., Tassa A., Ferrara M. Leucine limitation induces autophagy and activation of lysosome-dependent proteolysis in C2C12 myotubes through a mammalian target of rapamycin-independent signaling pathway. J Biol Chem. 2000 Sep 22;275(38):29900–29906. doi: 10.1074/jbc.M003633200. [DOI] [PubMed] [Google Scholar]
  33. Mulligan H. D., Tisdale M. J. Metabolic substrate utilization by tumour and host tissues in cancer cachexia. Biochem J. 1991 Jul 15;277(Pt 2):321–326. doi: 10.1042/bj2770321. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Newsholme E. A., Board M. Application of metabolic-control logic to fuel utilization and its significance in tumor cells. Adv Enzyme Regul. 1991;31:225–246. doi: 10.1016/0065-2571(91)90015-e. [DOI] [PubMed] [Google Scholar]
  35. Omura S., Fujimoto T., Otoguro K., Matsuzaki K., Moriguchi R., Tanaka H., Sasaki Y. Lactacystin, a novel microbial metabolite, induces neuritogenesis of neuroblastoma cells. J Antibiot (Tokyo) 1991 Jan;44(1):113–116. doi: 10.7164/antibiotics.44.113. [DOI] [PubMed] [Google Scholar]
  36. Pisters P. W., Brennan M. F. Amino acid metabolism in human cancer cachexia. Annu Rev Nutr. 1990;10:107–132. doi: 10.1146/annurev.nu.10.070190.000543. [DOI] [PubMed] [Google Scholar]
  37. Reitzer L. J., Wice B. M., Kennell D. Evidence that glutamine, not sugar, is the major energy source for cultured HeLa cells. J Biol Chem. 1979 Apr 25;254(8):2669–2676. [PubMed] [Google Scholar]
  38. Seglen P. O. DNA ploidy and autophagic protein degradation as determinants of hepatocellular growth and survival. Cell Biol Toxicol. 1997 Jul;13(4-5):301–315. doi: 10.1023/a:1007487425047. [DOI] [PubMed] [Google Scholar]
  39. Seglen P. O. Inhibitors of lysosomal function. Methods Enzymol. 1983;96:737–764. doi: 10.1016/s0076-6879(83)96063-9. [DOI] [PubMed] [Google Scholar]
  40. Smith P. K., Krohn R. I., Hermanson G. T., Mallia A. K., Gartner F. H., Provenzano M. D., Fujimoto E. K., Goeke N. M., Olson B. J., Klenk D. C. Measurement of protein using bicinchoninic acid. Anal Biochem. 1985 Oct;150(1):76–85. doi: 10.1016/0003-2697(85)90442-7. [DOI] [PubMed] [Google Scholar]
  41. Sutherland R. M. Cell and environment interactions in tumor microregions: the multicell spheroid model. Science. 1988 Apr 8;240(4849):177–184. doi: 10.1126/science.2451290. [DOI] [PubMed] [Google Scholar]
  42. Tayek J. A. A review of cancer cachexia and abnormal glucose metabolism in humans with cancer. J Am Coll Nutr. 1992 Aug;11(4):445–456. doi: 10.1080/07315724.1992.10718249. [DOI] [PubMed] [Google Scholar]
  43. Temparis S., Asensi M., Taillandier D., Aurousseau E., Larbaud D., Obled A., Béchet D., Ferrara M., Estrela J. M., Attaix D. Increased ATP-ubiquitin-dependent proteolysis in skeletal muscles of tumor-bearing rats. Cancer Res. 1994 Nov 1;54(21):5568–5573. [PubMed] [Google Scholar]
  44. Torosian M. H. Stimulation of tumor growth by nutrition support. JPEN J Parenter Enteral Nutr. 1992 Nov-Dec;16(6 Suppl):72S–75S. doi: 10.1177/014860719201600607. [DOI] [PubMed] [Google Scholar]
  45. Tournu C., Obled A., Roux M. P., Deval C., Ferrara M., Béchet D. M. Glucose controls cathepsin expression in Ras-transformed fibroblasts. Arch Biochem Biophys. 1998 Dec 1;360(1):15–24. doi: 10.1006/abbi.1998.0916. [DOI] [PubMed] [Google Scholar]
  46. Vaupel P., Kallinowski F., Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res. 1989 Dec 1;49(23):6449–6465. [PubMed] [Google Scholar]
  47. van Deurs B., Holm P. K., Sandvig K. Inhibition of the vacuolar H(+)-ATPase with bafilomycin reduces delivery of internalized molecules from mature multivesicular endosomes to lysosomes in HEp-2 cells. Eur J Cell Biol. 1996 Apr;69(4):343–350. [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES